Biphenyl carboxylic acids and bioisosteres as glycogen synthase activators
申请人:Hoffman-La Roche Inc.
公开号:US08039495B2
公开(公告)日:2011-10-18
Provided herein are compounds of the formula (I):
as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.
[EN] BIPHENYL CARBOXYLIC ACIDS AND BIOISOSTERES AS GLYCOGEN SYNTHASE ACTIVATORS<br/>[FR] ACIDES BIPHÉNYLCARBOXYLIQUES ET BIOISOSTÈRES COMME ACTIVATEURS DU GLYCOGÈNE SYNTHASE
申请人:HOFFMANN LA ROCHE
公开号:WO2011058154A1
公开(公告)日:2011-05-19
Provided herein are compounds of the formula (I) as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.
BIPHENYL CARBOXYLIC ACIDS AND BIOISOSTERES AS GLYCOGEN SYNTHASE ACTIVATORS
申请人:Bolin David Robert
公开号:US20110118322A1
公开(公告)日:2011-05-19
Provided herein are compounds of the formula (I):
as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.